Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Good morning England and congratulations to Synairgen share holders who have seen their shares go up 0.77% today, to just under 11p.
I am curious. Humour me. A company with one failed drug, no trials, no meaningful news in 12 months and with money to last only until the end of the year before a fund raise is needed.
So much hope and optimism for this company by legendary zealots after they have lost 97.5% of their wealth.
My curiosity is furnaced by the excitement and passion in the zealotry that the gang still have for this company and the staunch iron-sided allegiance they pledge to the CEO who has lost them 97.5% of their wealth.
Astonishing.
So what are the reasons for this sworn allegiance to Marsden? Any other company would have sacked their CEO a long time ago, but the gang of Synairgen zealots on this forum defend at all costs.
Drew x
Let me ask a question
Am I wrong?
My target price of 11p was reached.
Then my target price of 10p.
Now my target price is 8p, let’s see if I am right or wrong.
The gang have continuously been wrong.
Wrong on STRIVE,
Wrong on Bill Gates,
Wrong on SPAC merger (wtf happened there?)
Wrong on Polygon
Wrong on big pharma giving Synairgen a free trial (why on earth would they?)
Yet my target price keeps being reached.
Next target price is 8p, incoming.
Drew x
Dudio it’s not me that’s doing the work, you have to thank Marsden and the staff at Synairgen. They are the ones that are causing the share price to go down, not me.
Your problem is that you have failed to account for a fund raise. When the money runs out at the end of the year, if Synairgen aren’t magically on a free trial, then the dilution of shares from a fund raise will lower the share price to an even lower level. In fact, your holding will be diluted to a third.
If no one wants to fund the company because of their dismal past, then it’s Goodnight Vienna for Synairgen and all your money.
You could always email Brook and thank her for dropping the share price to 10p, ask her nicely if Marsden can drop the price to 4p so you can top up more?
Drew x
I’ve set a new target price of 8p based on zero news in the next 6 months.
If you bought in today, you’ll lose 30% of your money within a few more months time.
Add that to Tommy’s loss from when he invested at 24p.
If you’re going to double down on this company for the speculative punt (that’s all they are), at least wait until they reach 6-8p again.
Why do you think my antics causes the share price to drop?
People on this forum have a very strange belief that the forum affects the share price.
Rampers try their hardest to elevate the share price despite it falling 97% since its peaks. Yet it is Marsden and Synairgen that are the ones who cause the share price to go down with their useless ability.
The more useless a company is = the lower the share price goes. Synairgen are useless, as has been shown by 20 years of failure, combined with a year of ‘working at haste’ with zero news of any merit at all. Millions spent on wages and zero news.
You were foolish to buy in the 10’s today because as I wrote two days ago the price will go in to the 8’s. When the price goes in to the 8’s once again I will make a post and remind you of your foolishness, but you will then attack me (instead of Marsden, the man who is losing you your money).
When the fund raise comes, the price will see historic lows.
I keep on telling you people and yet you don’t seem to understand. Your relentless zealotry to keep putting money in to a company that has been utterly useless up until now is either admiring or total nativity.
When the share price falls to 6-8p again, then you will have lost a further 30-40% of your investment today.
If you’re going to take a punt, take the punt when the share price collapses at the next fund raise and share dilution.
Remember, Marsden et co are the people who LOST YOU YOUR MONEY with their utterly ridiculous trial.
You decided to invest your money in a company with useless staff. Instead of blaming the people that lost you money, you continue to support them and blame other people who used to be invested :-D
It’s laughable.
Well done on investing today, get ready to lose a further 30% soon enough.
A real early morning start here on the East coast today.
Scrolling through the British markets to see Synairgen have plunged a further 5% now firmly in to the 10p’s.
I also see plenty of posts attacking my good self :-D
The one thing I can’t understand, you have seen your wealth in your shares fall from £2.20 to 10p and still your optimism and confidence in Marsden the CEO remains intact.
The gang continue to attack me, yet I am the one pointing out how terrible this company is.
I can’t understand. If the gang are invested, why are they not pointing out how terrible the CEO is? He is the one who has done nothing within the last year and is surely responsible for such a dismal share price?
Seriously, how old are the investors on this forum? You do realise that it is not me who is controlling the share price? It is the abysmal performance of the CEO and company that is causing the share price to fall.
I repeat, there are many small biotech companies out there which have multiple drugs that are already on trials. Synairgen have one failed drug and are not on a single trial. As a result they are years away from getting their drug to market and the markets are reflecting this.
8p target price incoming. Along with lots of moaning from angry rampers who are going to attack my good self, but of course completely ignore the CEO of this company. £2.20 to 10p, a hefty drop in wealth.
Wake up and smell the coffee, the writing is on the wall in front of you.
Drew
https://inews.co.uk/news/no-plan-vulnerable-covid-treatments-face-axe-2170834
It appears that your i newspaper is reporting that the three most popular covid treatments, all of which are approved by the FDA, are now going to be axed by your nhs.
Remdesivir, Evushield and Molnupiravir will all be axed on the nhs. Only Pfizer will be have the monopoly on covid treatments as Paxlovid becomes king within the nhs.
It is extremely likely that Synairgen which aren’t even approved would get any chance in the nhs if these other three names have been forced out.
It’s all about speed, business, money and acumen.
In a world where big pharma rules the roost, if these little biotech companies want to have their day then they have to have the speed, business and acumen to stand up and be counted with the big boys. It appears over the last 12 months that Marsden has no business haste, acumen or prowess, he is cowering away from the shareholders. Perhaps it’s time that the man whom so many of the ‘gang’ on here try to defend so much, wakes up to smell the coffee!
Dude, they work for the company.
All they do is ramp this garbage.
They defend Marsden at all costs.
Any little theory news about interferon and they plaster it over the board, despite Synairgen failing in 20 years to get interferon to market.
Any new respiratory virus and they start plastering it over the board, pretending it’s good news for Synairgen.
It’s no news for Synairgen, Synairgen can’t get their single research drug on a trial, let alone approved.
AJ, I wouldn’t be surprised if Synairgen are paying people to do ramping on this forum.
The company is a pile of garbage, it has failed consistently for decades now and has done nothing in the last 12 months of ‘working at haste’.
It pays a communications officer who does no communicating. So where is the money going?
Perhaps employing a dozen little rampers on forums to try and con naive retail investors in to parting with cash to keep their scam afloat.
They have one single research drug and it hasn’t been on trial for an entire year. Most other biotech companies have multiple research drugs on multiple different trials.
Something is very odd and very peculiar why this company attracts so many rampers on this forum when it has done absolutely nothing to deserve any ramping.
12 months worth of salaries for the entire Synairgen team for a couple of presentations. What communication has their comms officer been doing?
The latest ramp is that Astra Zeneca are planning something. Hehe, pull the other one.
Utter failures.
For the last 12 months Synairgen have not had any drug on any trial.
They currently lack the funding required to finance their own trial.
If we look at the timelines of their failed P3 trial, it took 6 months from when they received funds until the time they started their trial. This was ‘working at haste’ in the middle of a pandemic when the race was on and urgency was of the essence.
We can therefore assume that after acquiring funds for a new P3 trial it will take Synairgen at least 6 months to begin the trial.
Unfortunately for the company they are not at that stage yet because they do not have the funds available to commit to a P3 trial.
So the question is, when will Synairgen either do a fund raise (which will crash the SP to record lows) or be given money by big pharma to finance a new trial?
After the debacle that was their last P3, I do not think big pharma would be willing to give Synairgen money, the team can not be trusted. Astra Zeneca would certainly not be comfortable giving Marsden cash for a trial, given his history and record.
It looks increasingly likely that a fund raise will be necessary to find a way forward. Based on this, I think it will be at least a year until Synairgen are on another trial again and then at least another year until the results of that trial are announced.
At best an 18 month time frame, most likely over 24 months. In that time there will be a fund raise and the SP will go down considerably more.
It’s not late here in Scottsdale.
You keep ramping kids.
Keep on mentioning random respiratory virus’ that Synairgen can not treat because it does not have an approved drug.
They’ve been trying to get their drug approved for 20 years and failed. Let that sink in.
Do you not understand the process?
A biotech company has to fund a trial and then pass the trial. You saw the calamity that occurred in the previous P3 trial, you lost lots of money. Yet somehow you are ramping up this company when they don’t even have a trial 12 months after their catastrophic failure.
Without a trial, without funds for a trial, there is no hope of approval. This means there is no hope of any profit for Synairgen.
Elsol what has this got to do with Synairgen?
Synairgen don’t have an approved drug to tackle this new virus. They don’t even have a drug on a trial yet.
Pfizer have drugs to tackle this new virus, drugs that are already approved such as the antiviral Paxlovid and Merck have Molnupiravir.
But Synairgen have a single unapproved drug that failed its trial.
So I ask again, what has this got to do with Synairgen, when both Pfizer and Merck have drugs that are already approved and could be used to stop this virus (if necessary).
I don’t think you realise that until Synairgen get their drug to market, they have absolutely nothing.
Fruits, my predictions can’t be that useless, they have been correct every single time
1. Marsden (working at haste) has achieved nothing in a year
2 A year on, Synairgen have failed to get on a platform trial or a handout trial from big pharma
3 the SP first fell to the 12’s as I predicted (when tommy said he invested at 24p). Then when I called 11’s that has been realised as well.
Every single time those who ramp this share have been wrong in the last 12 months
What happened to STRIVE?
Bill Gates?
SPAC Merger?
Takeover bid?
It’s all delusion. They are a tiny biotech company without a single drug on a trial. They have nothing.
Look at the screen, 11.51p
Target price reached.
I’m going to be bold, setting a new target price of 9p
I predict zero news in the next six months (working at haste for 12 months has resulted in nothing, so another 6 months will achieve nothing either).
Once 9p is realised, the fund raise news will come.
Tommy, how does it feel when you bought in at 24p and said you were doubling down. It certainly doesn’t feel good.
Let’s see if my new target price is achieved.
Drew x
What has this got to do with Synairgen?
Synairgen are a company with an unapproved drug.
By posting up news of a potential new virus, it means absolutely nothing.
Until Synairgen have passed a P3 (and for that they must get on a P3 and fund their own P3) it means diddly squat.
The ramping brigade love to post up all little nuggets of information about new studies in interferon or new respiratory diseases. Why? It means diddly squat.
The only thing that means anything with a biotech company is that its product passes a P3 trial and gets approval.
It’s the same old laughable ramping. Only this time there is absolutely nothing to write about this awful company and useless staff, so the ramping is by mentioning some random interferon studies or some new virus (which will amount to nothing) that Synairgen can not even treat because it doesn’t have a drug which is approved.
MrCosts, you know this already.
Since when (other than during an emergency pandemic, where the emergency is now over) did governments or big pharma pay for trials of drugs?
Every other biotech company needs to fund their own trials.
It’s laughable that people on here still believe (or they’re paid to spread hype) that somehow Synairgen will be given a free trial by a government or big pharma with their already failed P3 drug. Even 12 months later, with zero news, they cling on to the last desperation of zealotry in Synairgen.
This is not a drug for incurable cancer.
This is a drug for respiratory viruses, of which there are already multiple other drugs that have passed their P3 trials.
Synairgen will have to do the same as every other biotech company and secure funds for their own trial.
Right now, the CSO should be planning a new trial to be put in to operation as soon as funds are realised. That’s what he gets paid for, to design trials, yet unlike any other small biotech companies, Synairgen has not been designing any trials for a year.
Maybe Mr Monk is doing that, however Mr Marsden has not said a thing for an entire year except the team ‘working at haste’.
A fund raise will be needed in order for Synairgen to put on a trial, Monk needs to make sure that when this trial happens (in 12-18 months from now) that the design is not a total flop like the previous P3 trial was.
Expect a fund raise and expect the share price to fall to historic lows.
Synairgen had their chance and fluffed it in an incredible fashion. Now they have to do exactly the same as every other biotech company that also fluffed it.
So this is the stage Synairgen are at:
1. 1 single research drug, failed P3 previously.
2. Not enough funds to fund their own trial.
3. Begging governments and big pharma for a free trial.
And now
4. Trying to raise awareness for a broad spectrum antiviral.
It seems that the timeline will be a very very long timeline before a trial is designed and Synairgen’s single asset can be put on to that trial.
They are basically at the drawing board trying to persuade big pharma or governments to give them a free trial by explaining the benefits of a broad spectrum antiviral.
At least the chief scientific officer is doing something.
It’s just laughable looking at you lot ask questions out of thin air.
How is interferon going to be used as a prophylactic when it can’t even get on a trial?
When you all post up utter garbage like this, pretending to potential investors that there is so much potential with Synairgen, are you forgetting that the company can’t finance their own trials and are begging for handouts? They’ve failed in 20 years to bring this drug to market and now you’re talking about it’s use as a prophylactic, are you really such delusional naive zealots?
There was so much potential with British Volt, it could have made electric car batteries for the future across the entire world, did you invest in British Volt?
Absolute hype train ramping jokers.
Synairgen can’t organise anything, look what happened when they organised their P3.
Maybe they should start hiring you all because you seem to have a lot better ideas than any of the scientific team or the CEO.
So Synairgen are doing another presentation and have paid money to present their phase 2 data at a convention in another desperate attempt to get big pharma to give them a free trial for their failed drug?
They’ve had a whole year and this approach has not worked so far.
At least they are working at haste though.
Virtually a year ago Marsden the CEO told investors that he was working at haste to get the company’s single drug on to a free trial.
Could it be that Marsden is dyslexic? He meant to write that he is ‘working at eshta’ and not ‘haste’?
Eshta is a word used to describe ‘great, ok, chilled out’.
It would explain a lot. Marsden meant eshta?
It’s more likely that Marsden meant eshta than it is likely that Synairgen are part of a SPAC merger or Bill Gates investing in them. Thoughts?